Linezolid for the treatment of patients with central nervous system infection (Q36729811)

15 August 2017

1 reference

title

Linezolid for the treatment of patients with central nervous system infection (English)

1 reference

15 August 2017

0 references

1 reference

2

Matthew E Falagas

1 reference

15 August 2017

Fotinie Ntziora

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

6 February 2007

1 reference

Annals of Pharmacotherapy

15 August 2017

published in

1 reference

15 August 2017

volume

41

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

296-308

1 reference

Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic

15 August 2017

cites work

1 reference

Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis

21 January 2018

1 reference

Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains

21 January 2018

1 reference

Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment

21 January 2018

1 reference

Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin

21 January 2018

1 reference

Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infection

21 January 2018

1 reference

Clinical experience with linezolid for the treatment of central nervous system infections

21 January 2018

1 reference

Linezolid in the treatment of brain abscess due to Peptostreptococcus

21 January 2018

1 reference

Successful medical treatment of multiple brain abscesses due to Nocardia farcinica in a paediatric renal transplant recipient.

21 January 2018

1 reference

Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid

21 January 2018

1 reference

Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus Endocarditis unresponsive to vancomycin therapy with linezolid.

21 January 2018

1 reference

Capnocytophaga spp. brain abscess in an immunocompetent host: problems in antimicrobial chemotherapy and literature review

21 January 2018

1 reference

Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium.

21 January 2018

1 reference

Sensorineural hearing loss associated with intrathecal vancomycin

21 January 2018

1 reference

Multi-system Infection with Nocardia farcinica-therapy with linezolid and minocycline

21 January 2018

1 reference

Clinical experience with linezolid for the treatment of nocardia infection

21 January 2018

1 reference

Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid

21 January 2018

1 reference

Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis

21 January 2018

1 reference

Linezolid for the treatment of central nervous system infections in neurosurgical patients

21 January 2018

1 reference

Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid

21 January 2018

1 reference

Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review

21 January 2018

1 reference

Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: case report and review of the literature

21 January 2018

1 reference

Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature

21 January 2018

1 reference

Dexamethasone in adults with bacterial meningitis

21 January 2018

1 reference

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections

21 January 2018

1 reference

Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial

21 January 2018

1 reference

Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme

21 January 2018

1 reference

Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence

21 January 2018

1 reference

Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia

21 January 2018

1 reference

Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.

21 January 2018

1 reference

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections

21 January 2018

1 reference

Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis

21 January 2018

1 reference

Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis

21 January 2018

1 reference

Peripheral neuropathy associated with prolonged use of linezolid

21 January 2018

1 reference

Linezolid and serotonergic drug interactions: a retrospective survey

21 January 2018

1 reference

Community-Acquired Bacterial Meningitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1H307

1 reference

15 August 2017

1 reference